{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:55:46Z","timestamp":1793620546247,"version":"4.5.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474678 81973694"],"award-info":[{"award-number":["82474678 81973694"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Internet hospitals have emerged as a vital approach for patients seeking treatment for hypertension, with a significant increase in antihypertensive medication prescriptions through these innovative models. However, prescribing characteristics and guideline concordance of these prescriptions remain unclear. This study aim to analyze the prescribing characteristics of Western medicine (WM) and Chinese patent medicine (CPM) for hypertension and assess their concordance with hypertension guidelines in Internet hospitals in China, providing insights for optimizing antihypertensive CPM management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional analysis was conducted using data from the Yinchuan Internet Medical Regulatory Platform (YIMRP) covering 87 enterprise-led Internet hospitals in China from 1 January 2018, to 31 March 2021. Visits diagnosed with hypertension and prescribed at least one oral antihypertensive medication (either WM or CPM) were included. Guideline concordance was evaluated by comparing prescribed individual antihypertensive WM and CPM in Internet hospitals with international and Chinese hypertension guidelines recommendations. Statistical analyses included descriptive statistics, association rule analysis, and guideline concordance assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 787,209 visits, 93.75% were prescribed WM alone, 4.72% CPM alone, and 1.52% a combination of CPM and WM. Calcium channel blockers (CCBs) (38.50%) was the most prescribed WM class, with nifedipine (19.67%) being the most common individual medication. Most prescriptions of antihypertensive WM were guideline-concordant. Among CPM prescriptions, only 181 (0.37%) included traditional Chinese medicine (TCM) syndrome diagnoses. Of the 38 prescribed antihypertensive CPM, only 7 were guideline-recommended. The most frequently prescribed CPM were Jiuqiang Naoliqing (17.67%), and Zhenju Jiangya tablet (14.74%), neither of which was recommended by the guidelines. The combinations of two CPM were frequently prescribed, but none of these combinations were recommended by guidelines. The most common dual CPM combination was Jiuqiang Naoliqing + Qiangli Dingxuan tablet\/capsule (<jats:italic>support<\/jats:italic> 8.65%, <jats:italic>confidence<\/jats:italic> 0.44%).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prescribing characteristics of antihypertensive WM in Internet hospitals closely align with those in offline hospitals with relatively satisfactory guideline concordance. However, some issues persist in antihypertensive CPM prescriptions, including the lack of TCM syndrome differentiation, frequent prescription of non-recommended CPM, and duplicate therapies. Strengthening CPM management in Internet hospitals is essential for optimizing hypertension care.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fphar.2025.1580787","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T05:32:55Z","timestamp":1745818375000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Prescribing characteristics and guideline concordance of antihypertensive western and Chinese patent medicine in Internet hospitals in China: a cross-sectional study"],"prefix":"10.3389","volume":"16","author":[{"given":"Tiantian","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruogu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guozhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e041973","DOI":"10.1136\/bmjopen-2020-041973","article-title":"Impact of the 2017 ACC\/AHA guideline on the prevalence of elevated blood pressure and hypertension: a cross-sectional analysis of 10,799 individuals","volume":"10","author":"Alyabsi","year":"2020","journal-title":"BMJ Open"},{"key":"B2","doi-asserted-by":"publisher","first-page":"668843","DOI":"10.3389\/fphar.2021.668843","article-title":"Assessment of anti-hypertensive drug adherence by serial aldosterone-to-renin ratio measurement","volume":"12","author":"Buffolo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1186\/s12913-023-09675-2","article-title":"The construction and operational models of internet hospitals in China: a hospital-based survey study","volume":"23","author":"Chen","year":"2023","journal-title":"BMC Health Serv. Res."},{"key":"B4","unstructured":"Chinese pharmacopoeia\n          \n          \n          2020"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.jacc.2018.05.074","article-title":"2017 ACC\/AHA blood pressure treatment guideline recommendations and cardiovascular risk","volume":"72","author":"Colantonio","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.16439\/j.issn.1673-7245.2024.01.015","article-title":"Survey and analysis of hypertension co-administration by physicians in selected public hospitals in China","volume":"32","author":"Deng","year":"2024","journal-title":"Chin. J. Hypertens."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.15887\/j.cnki.13-1389\/r.2017.29.054","article-title":"Common issues and coping strategies for the rational application of Chinese medicines","volume":"10","author":"Fan","year":"2017","journal-title":"Chin. J. Clin. Ration. Drug Use"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1448471","DOI":"10.3389\/fpubh.2024.144847189\/fpubh.2024.1448471","article-title":"Implementation and evaluation of whole-course-based internet hospital outpatient pharmacy services: a cross-sectional study in western China","volume":"12","author":"Gao","year":"2024","journal-title":"Front. Public Health"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"B10","unstructured":"China\u2019s medium - and long term plan for the prevention and treatment of chronic non-communicable diseases (2017-2025)\n          \n          \n          2017"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e17995","DOI":"10.2196\/17995","article-title":"The internet hospital as a telehealth model in China: systematic search and content analysis","volume":"22","author":"Han","year":"2020","journal-title":"J. Med. Internet Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e1185","DOI":"10.1002\/hsr2.1185","article-title":"Blood pressure-lowering medication prescribing, its adherence to guidelines and relationship with blood pressure control at a family medicine department","volume":"6","author":"Harrison","year":"2023","journal-title":"Health Sci. Rep."},{"key":"B13","doi-asserted-by":"publisher","first-page":"107271","DOI":"10.1016\/j.vph.2023.1072712023.107271","article-title":"Therapy and guideline adherence at a multidisciplinary hypertension clinic: a prospective, observational study","volume":"154","author":"Hias","year":"2024","journal-title":"Vasc. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13020-024-01022-9","article-title":"The role of Chinese herbal medicine in the regulation of oxidative stress in treating hypertension: from therapeutics to mechanisms","volume":"19","author":"Jin","year":"2024","journal-title":"Chin. Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"6315","DOI":"10.3390\/cimb46070377","article-title":"The evolving role of calcium channel blockers in hypertension management: pharmacological and clinical considerations","volume":"46","author":"Jones","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12872-021-02054-x","article-title":"Concordance of recommendations across clinical practice guidelines for the management of hypertension in Southeast Asia with internationally reputable sources","volume":"21","author":"Kow","year":"2021","journal-title":"BMC Cardiovasc. Disord."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1161\/hypertensionaha.120.14836","article-title":"Underutilization of treatment for black adults with apparent treatment-resistant hypertension: JHS and the REGARDS study","volume":"76","author":"Langford","year":"2020","journal-title":"Hypertension"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/eurheartj\/ehac395","article-title":"Hypertension management in patients with cardiovascular comorbidities","volume":"44","author":"Lauder","year":"2023","journal-title":"Eur. Heart J."},{"key":"B19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12906-017-1946-2","article-title":"A national survey of Chinese medicine doctors and clinical practice guidelines in China","volume":"17","author":"Liu","year":"2017","journal-title":"BMC Complement. Altern. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"e2426135","DOI":"10.1001\/jamanetworkopen.2024.26135","article-title":"Barriers to optimal clinician guideline adherence in management of markedly elevated blood pressure: a qualitative study","volume":"7","author":"Lu","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12889-022-13271-0","article-title":"Global, regional, and national burden of hypertensive heart disease during 1990\u20132019: an analysis of the global burden of disease study 2019","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Public Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e059818","DOI":"10.1136\/bmj-2020-059818","article-title":"Clinical decision support in cardiovascular medicine","volume":"377","author":"Lu","year":"2022","journal-title":"Bmj"},{"key":"B23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3969\/j.issn.1674-2982.2017.07.010","article-title":"Analysis of outpatients's prescription utilization of Chinese Patent Medicines in primary health institutions from rural western China","volume":"10","author":"Luo","year":"2017","journal-title":"Chin. J. Health Policy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1e","DOI":"10.1714\/4361.43518","article-title":"2024 ESC Guidelines for the management of elevated blood pressure and hypertension","volume":"25","author":"McEvoy","year":"2024","journal-title":"G. Ital. Cardiol. (Rome)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3969\/j.issn.1000-3614.2024.07.001","article-title":"Report on cardiovascular health and diseases in China 2023: an updated summary","volume":"39","year":"2024","journal-title":"Chin. Circulation J."},{"key":"B26","unstructured":"Healthy China action (2019\u20132030)\n          \n          \n          2019"},{"key":"B27","unstructured":"National basic medical insurance, work injury insurance, and maternity insurance drug list (2023)\n          \n          \n          2023"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.16440\/j.cnki.1674-8166.2018.09.046","article-title":"Clinical effect observation of amlodipine benzenesulfonate combined with nifedipine in the treatment of essential hypertension","volume":"19","author":"Niu","year":"2018","journal-title":"J. Chronic Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jdmv.2023.10.010","article-title":"From guidelines to current practices: suboptimal hypertension management in France","volume":"48","author":"Paturle","year":"2023","journal-title":"J. Med. Vasc."},{"key":"B30","unstructured":"Yinchuan internet hospital supervision platform goes online\n          \n          \n          2018"},{"key":"B31","doi-asserted-by":"publisher","first-page":"102343","DOI":"10.1016\/j.cpcardiol.2023.102343","article-title":"Long-term systolic blood pressure variability independent of mean blood pressure is associated with mortality and cardiovascular events: a systematic review and meta-analysis","volume":"49","author":"Saputra","year":"2024","journal-title":"Curr. Probl. Cardiol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"217","DOI":"10.13422\/j.cnki.syfjx.20191521","article-title":"Expert consensus on diagnosis and treatment of hypertension with traditional Chinese medicine","volume":"25","year":"2019","journal-title":"Chin. J. Exp. Formulary."},{"key":"B33","unstructured":"Guiding principles for the clinical application of proprietary Chinese medicines\n          \n          \n          2010"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/s0140-6736(17)32476-5","article-title":"Availability, cost, and prescription patterns of antihypertensive medications in primary health care in China: a nationwide cross-sectional survey","volume":"390","author":"Su","year":"2017","journal-title":"Lancet"},{"key":"B35","doi-asserted-by":"publisher","first-page":"11962","DOI":"10.1038\/s41598-024-62923-1","article-title":"Analysis of online prescription patterns in Chinese patients with sequelae of cerebral infarction: a real-world study","volume":"14","author":"Tang","year":"2024","journal-title":"Sci. Rep."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1016\/j.jep.2014.07.047","article-title":"Prescription pattern of Chinese herbal products for hypertension in Taiwan: a population-based study","volume":"155","author":"Tsai","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4103\/ijpvm.IJPVM_379_19","article-title":"Adherence of general practitioners to the national hypertension guideline, isfahan, Iran","volume":"11","author":"Vatani Nezafat","year":"2020","journal-title":"Int. J. Prev. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1007\/s00108-008-2138-4","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies","volume":"49","author":"von Elm","year":"2008","journal-title":"Internist (Berl)"},{"key":"B39","doi-asserted-by":"publisher","first-page":"418206","DOI":"10.1155\/2014\/418206","article-title":"Traditional Chinese medicine syndromes for essential hypertension: a literature analysis of 13,272 patients","volume":"2014","author":"Wang","year":"2014","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"603","DOI":"10.16439\/j.issn.1673-7245.2024.07.002","article-title":"Chinese guidelines for the prevention and treatment of hypertension (2024 revision)","volume":"32","author":"Wang","year":"2024","journal-title":"Chin. J. Hypertens."},{"key":"B41","volume-title":"An empirical study on the influencing factors of medical service quality in Internet hospitals-taking Yinchun City as an example. [master\u2019s thesis]","author":"Wang","year":"2022"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1038\/s41371-021-00635-z","article-title":"Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China Hypertension Survey, 2012\u20132015","volume":"36","author":"Wang","year":"2022","journal-title":"J. Hum. Hypertens."},{"key":"B43","doi-asserted-by":"publisher","first-page":"68","DOI":"10.3969\/j.issn.1003-8914.2025.01.018","article-title":"Application of Achyranthis bidentatae radix in essential hypertension","volume":"40","author":"Wang","year":"2025","journal-title":"Guangming J. Chin. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/HJH.00000000000000650000000000065","article-title":"Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension","volume":"32","author":"Weber","year":"2014","journal-title":"J. Hypertens."},{"key":"B45","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines\/ASPC\/NMA\/PCNA guideline for the prevention\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur. Heart J."},{"key":"B47","unstructured":"Guidelines for ATC classification and DDD assignment 2023\n          \n          \n          2022"},{"key":"B48","doi-asserted-by":"publisher","first-page":"24","DOI":"10.7661\/j.cjim.20211224.19","article-title":"2018 Chinese guidelines for the management of hypertension","volume":"24","year":"2019","journal-title":"Chin. Cardiovasc. J."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2840","DOI":"10.3390\/molecules29122840","article-title":"Characterization of the components and metabolites of Achyranthes bidentata in the plasma and brain tissue of rats based on ultrahigh performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HR-MS) resolution mass spectrometry (UHPLC-HR-MS)","volume":"29","author":"Wu","year":"2024","journal-title":"Molecules"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e239","DOI":"10.2196\/jmir.78547854","article-title":"Internet hospitals in China: cross-sectional survey","volume":"19","author":"Xie","year":"2017","journal-title":"J. Med. Internet Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"275279","DOI":"10.1155\/2013\/27527955\/2013\/275279","article-title":"Trends in the treatment of hypertension from the perspective of traditional Chinese medicine","volume":"2013","author":"Xiong","year":"2013","journal-title":"Evidence-Based Complementary Altern. Med."},{"key":"B52","doi-asserted-by":"publisher","first-page":"773","DOI":"10.7661\/j.cjim.20211224.197","article-title":"Clinical practice guidelines of Chinese patent medicine for essential hypertension (2021)","volume":"42","author":"Xu","year":"2022","journal-title":"Chin. J. Integr. Med."},{"key":"B53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1142\/S0192415X2150014200142","article-title":"Trends and patterns in traditional Chinese medicine use among Chinese population in late adulthood: an eight-year repeated panel survey","volume":"49","author":"Xu","year":"","journal-title":"Am. J. Chin. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e21825","DOI":"10.2196\/21825","article-title":"Assessment of internet hospitals in China during the COVID-19 pandemic: national cross-sectional data analysis study","volume":"23","author":"Xu","year":"","journal-title":"J. Med. Internet Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1080\/07853890.2022.2162113","article-title":"Analysis of prescription status of antihypertensive drugs in Chinese patients with hypertension based on real-world study","volume":"55","author":"Yang","year":"2023","journal-title":"Ann. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s13063-024-08145-2","article-title":"Disagreements in risk of bias assessment for randomized controlled trials in hypertension-related Cochrane reviews","volume":"25","author":"Yao","year":"2024","journal-title":"Trials"},{"key":"B57","doi-asserted-by":"publisher","first-page":"961","DOI":"10.12102\/j.issn.1672-1349.2019.07.001","article-title":"Efficacy and safety of qingnao jiangya patent medicine in the treatment of primary hypertension: a systematic review","volume":"17","author":"Yu","year":"2019","journal-title":"Chin. J. Integr. Med. Cerebrovascuiar Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e39965","DOI":"10.2196\/39965","article-title":"Implementation of shared decision-making within internet hospitals in China based on patients' needs: feasibility study and content analysis","volume":"7","author":"Yu","year":"2023","journal-title":"JMIR Form. Res."},{"key":"B59","doi-asserted-by":"publisher","first-page":"155999","DOI":"10.1016\/j.metabol.2024.155999","article-title":"Global burden of metabolic diseases, 1990-2021","volume":"160","author":"Zhang","year":"","journal-title":"Metabolism"},{"key":"B60","doi-asserted-by":"publisher","first-page":"273","DOI":"10.21037\/hbsn-2022-10","article-title":"The internet hospital: how to combine with traditional healthcare model","volume":"11","author":"Zhang","year":"2022","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"B61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3969\/j.issn.1673-7571.2020.09.004","article-title":"The development prospect of internet medicine under the epidemic situation","volume":"15","author":"Zhang","year":"2020","journal-title":"China Digit. Health"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e38649","DOI":"10.1016\/j.heliyon.2024.e38649","article-title":"Exploring synergistic effects of Achyranthes bidentata Blume and Paeonia lactiflora Pall. on hypertension with liver yang hyperactivity using the multidisciplinary integrative strategy","volume":"10","author":"Zhang","year":"","journal-title":"Heliyon"},{"key":"B63","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41440-023-01470-0","article-title":"Copublication promotes dissemination hypertension guidelines: a retrospective cohort study","volume":"47","author":"Zhu","year":"2024","journal-title":"Hypertens. Res."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1580787\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T08:27:50Z","timestamp":1746001670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2025.1580787\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,28]]},"references-count":63,"alternative-id":["10.3389\/fphar.2025.1580787"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2025.1580787","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,28]]},"article-number":"1580787"}}